VFA
IBB icon

Valeo Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Valeo Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$383K Buy
1,818
+172
+10% +$34.5K 0.01% 548
2026
Q2 		$313K Sell
1,646
-29
-2% -$4.99K 0.01% 614
2026
Q1 		$283K Sell
1,675
-15
-0.9% -$2.56K 0.01% 574
2025
Q4 		$285K Buy
1,690
+291
+21% +$47.3K 0.01% 640
2025
Q3 		$202K Buy
+1,399
New +$191K ﹤0.01% 758
2024
Q4 		– Sell
-1,417
Closed -$206K – 764
2024
Q3 		$206K Buy
+1,417
New +$205K 0.01% 648
2023
Q2 		– Sell
-2,135
Closed -$276K – 643
2023
Q1 		$276K Buy
2,135
+486
+29% +$63.6K 0.01% 465
2022
Q4 		$216K Buy
+1,649
New +$213K 0.01% 466
2022
Q2 		– Sell
-3,185
Closed -$415K – 572
2022
Q1 		$415K Buy
3,185
+881
+38% +$115K 0.02% 370
2021
Q4 		$352K Hold
2,304
– – 0.02% 382
2021
Q3 		$373K Sell
2,304
-400
-15% -$67.3K 0.02% 358
2021
Q2 		$442K Buy
2,704
+717
+36% +$110K 0.03% 283
2021
Q1 		$299K Sell
1,987
-109
-5% -$17.3K 0.01% 356
2020
Q4 		$318K Sell
2,096
-76
-3% -$10.9K 0.02% 322
2020
Q3 		$294K Sell
2,172
-3
-0.1% -$407 0.03% 260
2020
Q2 		$297K Buy
2,175
+11
+0.5% +$1.4K 0.03% 254
2020
Q1 		$246K Sell
2,164
-1,781
-45% -$205K 0.03% 259
2019
Q4 		$475K Buy
3,945
+2,955
+298% +$330K 0.05% 198
2019
Q3 		$99K Sell
990
-1,010
-51% -$106K 0.01% 439
2019
Q2 		$218K Sell
2,000
-547
-21% -$58.2K 0.03% 271
2019
Q1 		$285K Buy
2,547
+1,800
+241% +$197K 0.03% 226
2018
Q4 		$72K Sell
747
-84
-10% -$8.92K 0.01% 433
2018
Q3 		$86K Buy
831
+84
+11% +$9.89K 0.01% 432
2018
Q2 		$87K Hold
747
– – 0.01% 423
2018
Q1 		$80K Sell
747
-15
-2% -$1.66K 0.01% 404
2017
Q4 		$81K Buy
762
+120
+19% +$12.8K 0.01% 378
2017
Q3 		$71K Buy
+642
New +$68.6K 0.02% 346

Other funds holding IBB

AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
KIG
Kessler Investment Group Columbus, Indiana $207M AUM 43.85% 1-Year Est. Return
DI
Decision Investments San Diego, California $110M AUM 52.83% 1-Year Est. Return

Valeo Financial Advisors's IBB Position: Q3 2026 in Review

Valeo Financial Advisors increased its iShares Biotechnology ETF (IBB) stake by 10% in Q3 2026, buying an estimated $34.5K and bringing the position to 1,818 shares worth $383K. The position accounts for 0.01% of the portfolio, ranked #548.

Valeo Financial Advisors first reported a position in IBB in Q3 2017 and has held it in 27 quarters since. The position peaked at $475K in Q4 2019. 37 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Valeo Financial Advisors held 1,818 shares of iShares Biotechnology ETF worth $383K as of Q3 2026.
  • Valeo Financial Advisors bought 172 iShares Biotechnology ETF shares in Q3 2026, an estimated $34.5K.
  • iShares Biotechnology ETF made up 0.01% of Valeo Financial Advisors's portfolio in Q3 2026, its #548 holding.
  • Valeo Financial Advisors first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 27 quarters since.
  • Valeo Financial Advisors's iShares Biotechnology ETF position peaked at $475K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Valeo Financial Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.